Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Uchiyama Holdings CoTSE:6059 -0.55%62 Debt-to-EBITDA is 15.40 as of Mar. 2026, which is 73% above its 10-year median of 8.89. GuruFocus rates TSE:6059 with a GF Score™ of 62/100 and a GF Value™ of 円359.43 (Fairly Valued). The stock has 7 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Uchiyama Holdings Co ranks worse than 89.38% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Uchiyama Holdings Co's Debt-to-EBITDA or its related term are showing as below:
TSE:6059'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -25.58 Med: 8.89 Max: 23.3
Current: 9.23
During the past 13 years, the highest Debt-to-EBITDA Ratio of Uchiyama Holdings Co was 23.30. The lowest was -25.58. And the median was 8.89.
TSE:6059's Debt-to-EBITDA is ranked worse than 89.38% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs TSE:6059: 9.23
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Uchiyama Holdings Co Debt-to-EBITDA Related Terms
Uchiyama Holdings Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Uchiyama Holdings Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6059 vs HCA, THC, EHC: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Uchiyama Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uchiyama Holdings Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Uchiyama Holdings Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Uchiyama Holdings Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Uchiyama Holdings Co (TSE:6059) has a Debt-to-EBITDA of 15.40 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Uchiyama Holdings Co. This is 73% above median its historical median of 8.89. According to the industry distribution chart, Uchiyama Holdings Co ranks #429 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 89.4%.
Is Uchiyama Holdings Co's Debt-to-EBITDA too high?
Uchiyama Holdings Co's current Debt-to-EBITDA of 15.40 is 73% above median its 10-year median of 8.89. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Uchiyama Holdings Co's value of 15.40 is 604.8% above this industry median. Based on the distribution chart, Uchiyama Holdings Co ranks #429 out of 480 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Uchiyama Holdings Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Uchiyama Holdings Co's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Uchiyama Holdings Co ranks #429 out of 480 companies for Debt-to-EBITDA. This places Uchiyama Holdings Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Uchiyama Holdings Co's value of 15.40 is 604.8% above this benchmark. While the company's 10-year median is 8.89 vs. the industry median of 2.19, Uchiyama Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uchiyama Holdings Co's current Debt-to-EBITDA of 15.40 is 604.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Uchiyama Holdings Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uchiyama Holdings Co's current Debt-to-EBITDA is 15.40, which is 73% above median its own 10-year median of 8.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uchiyama Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Uchiyama Holdings Co (TSE:6059) is currently considered Fairly Valued. The stock's GF Value™ is 円359.43, compared to a current price of 円364.00 — trading 1.3% above its estimated fair value. The current Debt-to-EBITDA is 15.40, which is 73% above median its 10-year median of 8.89 and 604.8% above the Healthcare Providers & Services industry median of 2.19. Uchiyama Holdings Co's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Uchiyama Holdings Co (TSE:6059), the current Debt-to-EBITDA is 15.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uchiyama Holdings Co (TSE:6059) Overvalued in 2026?
Based on GuruFocus' analysis, Uchiyama Holdings Co stock appears to be overvalued.
The current stock price of 円364.00 is trading 1.3% above its estimated GF Value™ of 円359.43.
GuruFocus considers Uchiyama Holdings Co to be Fairly Valued.
Key valuation signals for TSE:6059:
Debt-to-EBITDA: 15.40 (73% above median its 10-year median of 8.89)
GF Value™: 円359.43 vs. price of 円364.00 (1.3% above fair value)
Industry Position: 604.8% above the Healthcare Providers & Services median (#429 of 480)
No single metric tells the full story. See the TSE:6059 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uchiyama Holdings Co Ltd operates nursing care and hotel business through its subsidiary, Sawayaka club and karaoke business, food and drinks business, and real estate business through its subsidiary, Bonner Co. Ltd.
62GF Score
Get the complete analysis for TSE:6059
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6059 has been successfully added to your 
